Press Release – Biologix Hair is Suspending SEC Reporting

Snippet from the press release —

Biologix Hair Inc. announced that it filed a Form 15 as notice of suspension of the duty to file periodic reports under Sections 13 and 15(d) of the Securities Exchange Act of 1934 with the Securities and Exchange Commission (“SEC”) August 1, 2013. The Company is thereby voluntarily suspending its reporting obligations under the Securities Exchange Act of 1934.

As a result of filing Form 15, Biologix will no longer be required to file annual and quarterly reports with the SEC. The Company took this action in order to maximize management efficiency and cost effectiveness during its fast-paced development stage. The Company also aims to benefit from new capital-raising exemptions contained in the JOBS Act, which will allow registration exempt companies to raise up to $50 million in any 12-month period from accredited investors.

Read the rest — Biologix Hair Inc. Voluntarily Suspends SEC Reporting Obligations

A few months ago, a company called Biologix Hair had a heavy PR campaign going to announce their “breakthrough” hair loss treatment. As a result, their stock was at one point approximately $5.00/share. It closed last week at 11 cents a share and they are being delisted from the NASDAQ. What does that tell you about the product/company?

I can’t help but wonder the number of people who got caught up in the hair treatment frenzy from this company, which you can learn more about at their site.